Quantitation of urinary protein excretion is used extensively for diagnostic and prognostic purposes and to assess the effects of therapy. The method most commonly used to measure urinary protein relies on 24-hour urine collections, which are time consuming, cumbersome, and often inaccurate. We reasoned that the urinary protein/creatinine ratio in a single voided urine sample should correlate well with the quantity of protein in timed urine collections. In a study of 46 specimens we found an excellent correlation between the protein content of a 24-hour urine collection and the protein/creatinine ratio in a single urine sample. The best correlation was found when samples were collected after the first voided morning specimen and before bedtime. We conclude that the determination of the protein/creatinine ratio in single urine samples obtained during normal daylight activity, when properly interpreted by taking into consideration the effect of different rates of creatinine excretion, can replace the 24-hour urine collection in the clinical quantitation of proteinuria. In the presence of stable renal function, a protein/creatinine ratio of more than 3.5 (mg/mg) can be taken to represent "nephrotic-range" proteinuria, and a ratio of less than 0.2 is within normal limits.
This article has been cited by other articles:
Antunes, V. V. H., Veronese, F. J. V., Morales, J. V.
(2008). Diagnostic accuracy of the protein/creatinine ratio in urine samples to estimate 24-h proteinuria in patients with primary glomerulopathies: a longitudinal study. Nephrol Dial Transplant
23: 2242-2246
[Abstract][Full Text]
Papanna, R., Mann, L. K., Kouides, R. W., Glantz, J. C.
(2008). Protein/Creatinine Ratio in Preeclampsia: A Systematic Review. Obstet Gynecol
112: 135-144
[Abstract][Full Text]
Cote, A.-M., Brown, M. A, Lam, E., Dadelszen, P. v., Firoz, T., Liston, R. M, Magee, L. A
(2008). Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review. BMJ
336: 1003-1006
[Abstract][Full Text]
Waikar, S. S., Liu, K. D., Chertow, G. M.
(2008). Diagnosis, Epidemiology and Outcomes of Acute Kidney Injury. CJASN
3: 844-861
[Abstract][Full Text]
Khositseth, S., Sudjaritjan, N., Tananchai, P., Ong-ajyuth, S., Sitprija, V., Thongboonkerd, V.
(2008). Renal magnesium wasting and tubular dysfunction in leptospirosis. Nephrol Dial Transplant
23: 952-958
[Abstract][Full Text]
Mahmoodi, B. K., ten Kate, M. K., Waanders, F., Veeger, N. J.G.M., Brouwer, J.-L. P., Vogt, L., Navis, G., van der Meer, J.
(2008). High Absolute Risks and Predictors of Venous and Arterial Thromboembolic Events in Patients With Nephrotic Syndrome: Results From a Large Retrospective Cohort Study. Circulation
117: 224-230
[Abstract][Full Text]
Colla, L., Mesiano, P., Morellini, V., Besso, L., Cavallo, R., Bergallo, M., Costa, C., Merlino, C., Marcuccio, C., Fop, F., Lanfranco, G., Segoloni, G.P., Canavese, C., Stratta, P.
(2007). Human polyomavirus BK in patients with lupus nephritis: clinical and histological correlations. Lupus
16: 881-886
[Abstract]
Cheung, C. Y., Wong, K. M., Lee, M. P., Liu, Y. L., Kwok, H., Chung, R., Chau, K. F., Li, C. K., Li, C. S.
(2007). Prevalence of chronic kidney disease in Chinese HIV-infected patients. Nephrol Dial Transplant
22: 3186-3190
[Abstract][Full Text]
Matsumoto, Y., Lee, C., Shimada, S.
(2007). Effective treatment of four consecutive idiopathic membranous nephropathy patients. Nephrol Dial Transplant
22: 2726-2727
[Full Text]
Leanos-Miranda, A., Marquez-Acosta, J., Romero-Arauz, F., Cardenas-Mondragon, G. M., Rivera-Leanos, R., Isordia-Salas, I., Ulloa-Aguirre, A.
(2007). Protein:Creatinine Ratio in Random Urine Samples Is a Reliable Marker of Increased 24-Hour Protein Excretion in Hospitalized Women with Hypertensive Disorders of Pregnancy. Clin. Chem.
53: 1623-1628
[Abstract][Full Text]
Barratt, J. MB ChB (Ho, Topham, P. MB ChB MD
(2007). Urine proteomics: the present and future of measuring urinary protein components in disease. CMAJ
177: 361-368
[Abstract][Full Text]
Leung, Y. Y., Szeto, C. C., Tam, L. S., Lam, C. W. K., Li, E. K., Wong, K. C., Yu, S. W., Kun, E. W.
(2007). Urine protein-to-creatinine ratio in an untimed urine collection is a reliable measure of proteinuria in lupus nephritis. Rheumatology (Oxford)
46: 649-652
[Abstract][Full Text]
Kostapanos, M. S., Milionis, H. J., Gazi, I., Kostara, C., Bairaktari, E. T., Elisaf, M.
(2006). Rosuvastatin Increases {alpha}-1 Microglobulin Urinary Excretion in Patients With Primary Dyslipidemia.. J Clin Pharmacol
46: 1337-1343
[Abstract][Full Text]
Price, C. P., Newall, R. G., Boyd, J. C.
(2005). Use of Protein:Creatinine Ratio Measurements on Random Urine Samples for Prediction of Significant Proteinuria: A Systematic Review. Clin. Chem.
51: 1577-1586
[Abstract][Full Text]
Al, R. A., Baykal, C., Karacay, O., Geyik, P. O., Altun, S., Dolen, I.
(2004). Random Urine Protein-Creatinine Ratio to Predict Proteinuria in New-Onset Mild Hypertension in Late Pregnancy. Obstet Gynecol
104: 367-371
[Abstract][Full Text]
Yuyun, M. F., Khaw, K.-T., Luben, R., Welch, A., Bingham, S., Day, N. E., Wareham, N. J.
(2004). A Prospective Study of Microalbuminuria and Incident Coronary Heart Disease and Its Prognostic Significance in a British Population: The EPIC-Norfolk Study. Am J Epidemiol
159: 284-293
[Abstract][Full Text]
Heine, G. H., Sester, U., Girndt, M., Kohler, H.
(2004). Acanthocytes in the Urine: Useful tool to differentiate diabetic nephropathy from glomerulonephritis?. Diabetes Care
27: 190-194
[Abstract][Full Text]
Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., Eknoyan, G.
(2003). National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. ANN INTERN MED
139: 137-147
[Abstract][Full Text]
Chadban, S. J., Briganti, E. M., Kerr, P. G., Dunstan, D. W., Welborn, T. A., Zimmet, P. Z., Atkins, R. C.
(2003). Prevalence of Kidney Damage in Australian Adults: The AusDiab Kidney Study. J. Am. Soc. Nephrol.
14: S131-138
[Abstract][Full Text]
Craig, K. J., Donovan, K., Munnery, M., Owens, D. R., Williams, J. D., Phillips, A. O.
(2003). Identification and Management of Diabetic Nephropathy in the Diabetes Clinic. Diabetes Care
26: 1806-1811
[Abstract][Full Text]
Norman, L. P., Jiang, W., Han, X., Saunders, T. L., Bond, J. S.
(2003). Targeted Disruption of the Meprin {beta} Gene in Mice Leads to Underrepresentation of Knockout Mice and Changes in Renal Gene Expression Profiles. Mol. Cell. Biol.
23: 1221-1230
[Abstract][Full Text]
Hong, C.-Y., Hughes, K., Chia, K.-S., Ng, V., Ling, S.-L.
(2003). Urinary {alpha}1-Microglobulin as a Marker of Nephropathy in Type 2 Diabetic Asian Subjects in Singapore. Diabetes Care
26: 338-342
[Abstract][Full Text]
Krakoff, J., Lindsay, R. S., Looker, H. C., Nelson, R. G., Hanson, R. L., Knowler, W. C.
(2003). Incidence of Retinopathy and Nephropathy in Youth-Onset Compared With Adult-Onset Type 2 Diabetes. Diabetes Care
26: 76-81
[Abstract][Full Text]
Regeniter, A., Steiger, J. U., Scholer, A., Huber, P. R., Siede, W. H.
(2003). Windows to the Ward: Graphically Oriented Report Forms. Presentation of Complex, Interrelated Laboratory Data for Electrophoresis/Immunofixation, Cerebrospinal Fluid, and Urinary Protein Profiles. Clin. Chem.
49: 41-50
[Abstract][Full Text]
Sato, A., Hayashi, K., Naruse, M., Saruta, T.
(2003). Effectiveness of Aldosterone Blockade in Patients With Diabetic Nephropathy. Hypertension
41: 64-68
[Abstract][Full Text]
Lepore, G., Maglio, M. L., Nosari, I., Dodesini, A. R., Trevisan, R.
(2002). Cost-Effectiveness of Two Screening Programs for Microalbuminuria in Type 2 Diabetes. Diabetes Care
25: 2103-2104
[Full Text]
Looker, H. C., Knowler, W. C., Hanson, R. L.
(2001). Changes in BMI and Weight Before and After the Development of Type 2 Diabetes. Diabetes Care
24: 1917-1922
[Abstract][Full Text]
Sánchez-Carbayo, M., Urrutia, M., de Buitrago, J. M. G., Navajo, J. A.
(2000). Evaluation of Two New Urinary Tumor Markers: Bladder Tumor Fibronectin and Cytokeratin 18 for the Diagnosis of Bladder Cancer. Clin. Cancer Res.
6: 3585-3594
[Abstract][Full Text]
Bashir, K., Whitaker, J. N.
(1999). Clinical and laboratory features of primary progressive and secondary progressive MS. Neurology
53: 765-765
[Abstract][Full Text]
Matos, V., Drukker, A., Guignard, J.-P.
(1999). Spot urine samples for evaluating solute excretion in the first week of life. Arch. Dis. Child. Fetal Neonatal Ed.
80: 240F-242
[Abstract][Full Text]
Remuzzi, G., Bertani, T.
(1998). Pathophysiology of Progressive Nephropathies. NEJM
339: 1448-1456
[Full Text]
Ruggenenti, P., Gaspari, F., Perna, A., Remuzzi, G.
(1998). Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes. BMJ
316: 504-509
[Abstract][Full Text]
Goonasekera, C D A, Shah, V, Rees, D D, Dillon, M J
(1997). Nitric oxide activity in childhood hypertension. Arch. Dis. Child.
77: 11-16
[Abstract][Full Text]
Miettinen, H., Haffner, S. M., Lehto, S., Ronnemaa, T., Pyorala, K., Laakso, M.
(1996). Proteinuria Predicts Stroke and Other Atherosclerotic Vascular Disease Events in Nondiabetic and Non–Insulin-Dependent Diabetic Subjects. Stroke
27: 2033-2039
[Abstract][Full Text]